Similarly, CD58 correlated with MSI in breast invasive carcinoma (BRCA), CESC, KICH, LUAD, ovarian serous cystadenocarcinoma (OV), pheochromocytoma and paraganglioma (PCPG), THCA, and UCEC. This evidence concerns the gene CD58 and pheochromocytoma.